Class I histone deacetylase inhibition ameliorates social cognition and cell adhesion molecule plasticity deficits in a rodent model of autism spectrum disorder
|Title:||Class I histone deacetylase inhibition ameliorates social cognition and cell adhesion molecule plasticity deficits in a rodent model of autism spectrum disorder||Authors:||Foley, Andrew G.
Cassidy, Andrew W.
Regan, Ciaran M.
|Permanent link:||http://hdl.handle.net/10197/3779||Date:||Sep-2012||Online since:||2012-09-04T14:20:47Z||Abstract:||In utero exposure of rodents to valproic acid (VPA), a histone deacetylase (HDAC) inhibitor, has been proposed to induce an adult phenotype with behavioural characteristics reminiscent of those observed in autism spectrum disorder (ASD). We have evaluated the face validity of this model in terms of social cognition deficits which are a major core symptom of ASD. We employed the social approach avoidance paradigm as a measure of social reciprocity, detection of biological motion that is crucial to social interactions, and spatial learning as an indicator of dorsal stream processing of social cognition and found each parameter to be significantly impaired in Wistar rats with prior in utero exposure to VPA. We found no significant change in the expression of neural cell adhesion molecule polysialylation state (NCAM PSA), a measure of construct validity, but a complete inability to increase its glycosylation state which is necessary to mount the neuroplastic response associated with effective spatial learning. Finally, in all cases, we found chronic HDAC inhibition, with either pan-specific or HDAC1-3 isoform-specific inhibitors, to significantly ameliorate deficits in both social cognition and its associated neuroplastic response. We conclude that in utero exposure to VPA provides a robust animal model for the social cognitive deficits of ASD and a potential screen for the development of novel therapeutics for this condition.||Funding Details:||Not applicable||Type of material:||Journal Article||Publisher:||Elsevier||Journal:||Neuropharmacology||Volume:||63||Issue:||4||Start page:||750||End page:||760||Copyright (published version):||2012 Elsevier Ltd.||Keywords:||SAHA; NCAM PSA; MS-275; VPA; Histone deacetylase; Social interaction; Biological motion; Spatial learning; Synaptic plasticity||Subject LCSH:||Valproic acid
Autism spectrum disorder (ASD)
|DOI:||10.1016/j.neuropharm.2012.05.042||Language:||en||Status of Item:||Peer reviewed|
|Appears in Collections:||Biomolecular and Biomedical Science Research Collection|
Show full item record
This item is available under the Attribution-NonCommercial-NoDerivs 3.0 Ireland. No item may be reproduced for commercial purposes. For other possible restrictions on use please refer to the publisher's URL where this is made available, or to notes contained in the item itself. Other terms may apply.